Mueller, Patricia W.

Diabetes Antibody Standardization Program: first assay proficiency evaluation

Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes

Diabetes and associated disordersClinical Laboratory Practices and Quality Control

Cited by 362

Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia

Bonifacio, E., Yu, L., Williams, A. K., Eisenbarth, G. S., Bingley, P. J., Marcovina, S. M., Adler, K., Ziegler, A. G., Mueller, P. W., Schatz, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism

Diabetes and associated disordersClinical Laboratory Practices and Quality Control

Cited by 291

Detection of antibodies directed to the N-terminal region of GAD is dependent on assay format and contributes to differences in the specificity of GAD autoantibody assays for type 1 diabetes

Williams, A. J. K., Lampasona, V., Schlosser, M., Mueller, P. W., Pittman, D. L., Winter, W. E., Akolkar, B., Wyatt, R., Brigatti, C., Krause, S., et al. (2015) · Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 46

Considerations when measuring urinary albumin: precision, substances that may interfere, and conditions for sample storage

MacNeil, M. L. W., Mueller, P. W., Caudill, S. P., & Steinberg, K. K. (1991) · Clinical Chemistry

Clinical Laboratory Practices and Quality ControlChronic Kidney Disease and Diabetes

Cited by 42

Standard enrichment methods for targeted next-generation sequencing in high-repeat genomic regions

Mueller, P. W., Lyons, J., Kerr, G., Haase, C. P., & Isett, R. B. (2013) · Genetics in Medicine

Genomics and Rare DiseasesGenomics and Phylogenetic Studies

Cited by 11